Posts Tagged ‘access to care’

A big change is afoot and the hype is cranking up. With the launch of Wegovy tablets by Novo Nordisk yesterday, we are seeing some very big expectations expressed for a new era in obesity care. The stock market has boosted the value of Novo stock by 15 percent since FDA approved these tablets. Yesterday […]

This has been quite a year that we are closing out on this New Year’s Eve. As we start another new year, we will be leaving behind an ample collection of curses we suffered and blessings we enjoyed in 2025. No doubt, you have your list. So here is our own brief list of the […]

This year is quickly winding down and with it, some unpleasant memories may, thankfully, fade. But for our interest in obesity and health, 2025 has been a very eventful year of progress, with five milestones that are particular standouts. So let’s pause and celebrate this progress. 1. Global Embrace of Obesity Care Perhaps the biggest […]

On this Christmas Day, we have a simple wish. It is the wish that equitable access to obesity care, free from stigma and blame, should be available to all. Right now, that is clearly not true. And there’s a lot to suggest that the trends are headed in precisely the wrong direction. Skimming the Cream […]

This has been quite a year. Many remarkable changes we’ve witnessed go well beyond the scope of this commentary. In the policy realm, some of them are close at hand. CDC, which has long guided health policy on obesity, nutrition, and physical activity, has been decimated. NIH is under extraordinary stress. But on the positive […]

The unmet need for delivering obesity care at scale is indisputably great. Just thinking about it is daunting because the need is so great. It will require new thinking. One thread of that new thinking is all of the innovation in telemedicine that’s unfolding before our eyes. In Obesity this month, we see yet another […]

Business is apparently booming in the criminal trade for bogus obesity medicines. The Times (London) reports that criminals are selling dangerous weight-loss jabs on social media and in gyms. They write that: “Pharmaceutical bosses have issued a stark warning about medicines such as Mounjaro sold online without safety controls as gangs branch out from hard […]

Truveta this week published data that reveals striking growth in the use of GLP-1s by women with PCOS (polycystic ovary syndrome). Prescriptions for semaglutide or tirzepatide have risen by more than 700% in women with PCOS, according to their analysis. So don’t think that this is slipping right by the bean counters at drug benefit […]

Americans are only barely aware of the role that pharmacy benefit managers play in health insurance. But what they do know is not good. To the extent that most people know anything about these shadowy players in health insurance, they know PBMs control which drugs they can get, how much hassle it is to get […]

Anyone who thought this would be a passing thing was way off the mark. As prices of GLP-1 medicines are falling, their use is rising. As Stat News notes, we now have more people using these medicines than the entire population of Texas. This rising trend occurs against a background of costs that are still […]